The Global Digestive Drugs Market encompassing therapeutics for conditions ranging from common acid reflux to severe Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS), is undergoing a transformative shift toward advanced biologics and targeted therapies. The report forecasts that the Digestive Drugs Market, valued at approximately $52.8 Billion in 2023,...